The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders
- PMID: 30643005
- PMCID: PMC6356015
- DOI: 10.1042/BSR20180773
The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders
Abstract
Inhibitor of growth 4 (ING4), a member of the ING family discovered in 2003, has been shown to act as a tumor suppressor and is frequently down-regulated in various human cancers. Numerous published in vivo and in vitro studies have shown that ING4 is responsible for important cancer hallmarks such as pathologic cell cycle arrest, apoptosis, autophagy, contact inhibition, and hypoxic adaptation, and also affects tumor angiogenesis, invasion, and metastasis. These characteristics are typically associated with regulation through chromatin acetylation by binding histone H3 trimethylated at lysine 4 (H3K4me3) and through transcriptional activity of transcription factor P53 and NF-κB. In addition, emerging evidence has indicated that abnormalities in ING4 expression and function play key roles in non-neoplastic disorders. Here, we provide an overview of ING4-modulated chromosome remodeling and transcriptional function, as well as the functional consequences of different genetic variants. We also present the current understanding concerning the role of ING4 in the development of neoplastic and non-neoplastic diseases. These studies offer inspiration for pursuing novel therapeutics for various cancers.
Keywords: aberrant expression status; chromosome remodeling; gene therapy; inhibitor of growth 4; mechanisms; non-neoplastic diseases.
© 2019 The Author(s).
Conflict of interest statement
The authors declare that there are no competing interests associated with the manuscript.
Figures
Similar articles
-
The emerging role of inhibitor of growth 4 as a tumor suppressor in multiple human cancers.Cell Physiol Biochem. 2015;36(2):409-22. doi: 10.1159/000430108. Epub 2015 May 11. Cell Physiol Biochem. 2015. PMID: 25968091 Review.
-
Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.Technol Cancer Res Treat. 2015 Aug;14(4):369-78. doi: 10.1177/1533034614500424. Epub 2014 Oct 16. Technol Cancer Res Treat. 2015. PMID: 25326586
-
Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.Technol Cancer Res Treat. 2015 Oct;14(5):617-26. doi: 10.7785/tcrt.2012.500424. Epub 2014 Nov 26. Technol Cancer Res Treat. 2015. PMID: 24750000
-
Adenovirus-mediated ING4/IL-24 double tumor suppressor gene co-transfer enhances antitumor activity in human breast cancer cells.Oncol Rep. 2012 Oct;28(4):1315-24. doi: 10.3892/or.2012.1930. Epub 2012 Jul 24. Oncol Rep. 2012. PMID: 22842937
-
Inhibitor of growth-4 is a potential target for cancer therapy.Tumour Biol. 2016 Apr;37(4):4275-9. doi: 10.1007/s13277-016-4842-3. Epub 2016 Jan 23. Tumour Biol. 2016. PMID: 26803518 Review.
Cited by
-
Biological Functions of the ING Proteins.Cancers (Basel). 2019 Nov 19;11(11):1817. doi: 10.3390/cancers11111817. Cancers (Basel). 2019. PMID: 31752342 Free PMC article. Review.
-
Effect of bevacizumab on expression level of GLI1 and ING4 in colon cancer animal model.Oncol Lett. 2020 Aug;20(2):1263-1269. doi: 10.3892/ol.2020.11677. Epub 2020 May 28. Oncol Lett. 2020. PMID: 32724367 Free PMC article.
-
Deciphering the dual roles of PHD finger proteins from oncogenic drivers to tumor suppressors.Front Cell Dev Biol. 2024 May 15;12:1403396. doi: 10.3389/fcell.2024.1403396. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38813086 Free PMC article. Review.
-
Lentiviral vector with a radiation-inducible promoter, carrying the ING4 gene, mediates radiosensitization controlled by radiotherapy in cervical cancer cells.Oncol Lett. 2021 Jan;21(1):67. doi: 10.3892/ol.2020.12328. Epub 2020 Nov 25. Oncol Lett. 2021. PMID: 33365078 Free PMC article.
-
High level of H3K4 tri-methylation modification predicts poor prognosis in esophageal cancer.J Cancer. 2020 Mar 5;11(11):3256-3263. doi: 10.7150/jca.36801. eCollection 2020. J Cancer. 2020. PMID: 32231731 Free PMC article.
References
-
- Shiseki M., Nagashima M., Pedeux R.M., Kitahama-Shiseki M., Miura K., Okamura S.. et al. (2003) p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res. 63, 2373–2378 - PubMed
-
- Gunduz M., Nagatsuka H., Demircan K., Gunduz E., Cengiz B., Ouchida M.. et al. (2005) Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 356, 109–117 10.1016/j.gene.2005.02.01410.1016/j.gene.2005.02.014 - DOI - PubMed
-
- Kim S., Chin K., Gray J.W. and Bishop J.M. (2004) A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc. Natl. Acad. Sci. U.S.A. 101, 16251–16256 10.1073/pnas.040715810110.1073/pnas.0407158101 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous